Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · Real-Time Price · USD

4.800

+0.050 (1.05%)

At close: Aug 14, 2026, 4:00 PM EDT

4.752

-0.048 (-1.00%)

After-hours: Aug 14, 2026, 7:35 PM EDT

Relmada Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	512	354	16	125	105	625
Market Cap Growth	2609.08%	2157.41%	-87.41%	18.63%	-83.18%	19.93%
Enterprise Value	294	340	-38	18	-79	537
Last Close Price	4.80	4.83	0.52	4.14	3.49	22.53
PB Ratio	2.48	4.09	0.44	1.46	0.75	3.00
P/TBV Ratio	2.48	4.09	0.44	1.46	0.75	3.00
Net Debt / Equity Ratio	-1.05	-1.07	-1.26	-1.13	-1.06	-1.02
Net Debt / EBITDA Ratio	-	-	-	-	0.92	1.69
Net Debt / FCF Ratio	4.73	2.03	0.87	1.87	1.43	2.31
Quick Ratio	29.34	14.46	4.36	7.90	11.94	14.08
Current Ratio	29.52	14.62	4.45	8.00	12.26	14.83
Return on Equity (ROE)	-55.66%	-94.05%	-132.33%	-87.51%	-90.07%	-80.14%
Return on Assets (ROA)	-32.39%	-50.24%	-73.14%	-51.76%	-53.57%	-46.01%
Return on Capital Employed (ROCE)	-29.40%	-64.20%	-236.10%	-121.50%	-114.80%	-60.40%
Earnings Yield	-12.09%	-16.20%	-509.73%	-79.28%	-149.50%	-20.13%
FCF Yield	-8.98%	-12.93%	-329.85%	-41.46%	-98.81%	-14.71%
Buyback Yield / Dilution	-136.32%	-30.89%	-0.21%	-1.59%	-68.80%	-12.56%

SEC Filings: 10-K · 10-Q